Schizophrenia in a Primary Care Setting
- PMID: 26341756
- DOI: 10.1007/s11920-015-0620-y
Schizophrenia in a Primary Care Setting
Abstract
In recent years, the focus of mental health care for people with schizophrenia has shifted from an expectation of lifelong disability to a 'recovery' approach in which patients and specialists anticipate discharge to management within primary care. Although the active symptoms of mental illness are generally well-managed with modern pharmacotherapy, primary care physicians often express concern about their lack of understanding and expertise in general management of schizophrenia. Moreover, the ability of patients to access care for their physical disorders in a timely fashion together with a higher prevalence of physical co-morbidities is likely to be responsible for the greater mortality and premature death of this already stigmatised and disadvantaged group. This paper focuses on new evidence over the past 5 years, considering the management of physical and mental health of schizophrenia patients in primary care, optimal processes and the reasons why these may not always be realised in practice.
Similar articles
-
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. Encephale. 2009. PMID: 19748369 French.
-
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165. doi: 10.3310/hta10170. Health Technol Assess. 2006. PMID: 16707074 Clinical Trial.
-
The role of sex hormones in psychopathology: focus on schizophrenia.Prim Care. 2002 Mar;29(1):171-82, viii. doi: 10.1016/s0095-4543(03)00080-0. Prim Care. 2002. PMID: 11856665 Review.
-
Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs).Riv Psichiatr. 2016 Mar-Apr;51(2):47-59. doi: 10.1708/2246.24194. Riv Psichiatr. 2016. PMID: 27183509 Review.
-
Implementation of monitoring and management guidelines for second-generation antipsychotics.J Clin Psychiatry. 2007;68 Suppl 4:14-8. J Clin Psychiatry. 2007. PMID: 17539695
Cited by
-
Factors associated with visits to general practitioners in patients with schizophrenia in Malaga.BMC Fam Pract. 2018 Nov 28;19(1):180. doi: 10.1186/s12875-018-0866-7. BMC Fam Pract. 2018. PMID: 30486784 Free PMC article.
-
The perspectives of healthcare professionals in mental health settings on stigma and recovery - A qualitative inquiry.BMC Health Serv Res. 2022 Jul 9;22(1):888. doi: 10.1186/s12913-022-08248-z. BMC Health Serv Res. 2022. PMID: 35804378 Free PMC article.
-
Treatment Compliance in the Long-Term Paranoid Schizophrenia Telemedicine Study.J Technol Behav Sci. 2017;2(2):84-87. doi: 10.1007/s41347-017-0016-4. Epub 2017 May 18. J Technol Behav Sci. 2017. PMID: 29082310 Free PMC article.
-
Comparison of Elixhauser and Charlson Methods for Discriminative Performance in Mortality Risk in Patients with Schizophrenic Disorders.Int J Environ Res Public Health. 2020 Apr 3;17(7):2450. doi: 10.3390/ijerph17072450. Int J Environ Res Public Health. 2020. PMID: 32260241 Free PMC article.
-
The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review.BMC Psychiatry. 2021 Aug 4;21(1):390. doi: 10.1186/s12888-021-03355-3. BMC Psychiatry. 2021. PMID: 34348680 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous